Skip to content

Characterisation of voice and swallowing in individuals with chronic cough

Characterisation of upper aerodigestive tract dysfunction in individuals with chronic cough

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622000300774
Enrollment
8
Registered
2022-02-16
Start date
2022-06-27
Completion date
2023-10-31
Last updated
2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Chronic cough is a common condition, affecting between 9-33% of adults worldwide. Its cause is not well understood, making treatment challenging and leading to poor patient outcomes. Research suggests a link to laryngeal (voice box) dysfunction in this population, as indicated by increased sensitivity to inhaled substances (e.g., smoke or perfumes) and muscle tension in the throat. Impaired voice and swallowing have also been documented, further suggesting dysfunction in the larynx and upper airway. Additionally, traditional methods for treating voice disorders have been shown to reduce the severity and frequency of coughing in this group. Together, these suggest a common mechanism underlies chronic coughing and disorders of voice and swallowing. This study will examine laryngeal and broader upper airway function using assessments of voice, swallowing, coughing and breathing, to determine the characteristics of these in those with chronic cough. This will aid in establishing the mechanism that causes the condition. The study will include two groups, a chronic cough group and a healthy control group. The groups will be compared, to determine which aspects of upper airway function differ in the patient group compared to healthy controls.

Interventions

Please note that this study does not involve an intervention as such. However, because the study protocol (i.e., assessments used) goes beyond a typical medical investigation of patients with chronic cough, it cannot be classed as purely observational. All participants will undergo the following assessment protocol: - Questionnaire completed - Respiratory and respiratory-swallowing measures including a) assessment of breathing at rest (i.e., while seated in a chair, not talking or eating)

Please note that this study does not involve an intervention as such. However, because the study protocol (i.e., assessments used) goes beyond a typical medical investigation of patients with chronic cough, it cannot be classed as purely observational. All participants will undergo the following assessment protocol: - Questionnaire completed - Respiratory and respiratory-swallowing measures including a) assessment of breathing at rest (i.e., while seated in a chair, not talking or eating) b) spirometry (lung function testing) - Swallowing measures including a) Timed Water Swallow Test (TWST; drinking 150mL water as quickly as possible) b) Test of Masticating and Swallowing Solids (TOMASS; eating a cracker as quickly as possible) c) Videofluoroscopic Swallowing Study (VFSS), a video x-ray of participants whilst eating/drinking various amounts of water, and a cracker. Water will be mixed with a barium contrast powder to allow visualisation of the bolus on VFSS (69 g to every 150mL water). Barium contrast paste will be spread on cracker to thinly coat. - Voice assessment tasks including a) endoscopic voice imaging (using a flexible camera in the throat to assess gross anatomy) b) stroboscopic voice imaging (using the same flexible camera in the throat to assess vocal fold movement and vibration) c) audio recording of the voice, for offline analysis. Participants will do the following during the voice assessment: 1) humming 2) sustained vowel sounds "eee" and "aaa" 3) pitch glide (i.e., from lowest note to highest note, and back down, like a siren) 4) counting from 1-5 with increasing volume (i.e., from lowest non-whispering volume to shouting) 5) repetition of the sentence "how hard did he hit him" 6) conversation, prompted by asking the participant "tell me about your weekend" - Laryngeal sensitivity measures including: a) Presence or absence of the laryngeal adductor reflex i.e., whether a cough response occurs when the larynx (voice box) is touched with a flexible camera b) cough sensitivity threshold to an inhaled citric acid mist Most participants will undergo the above assessment once. This will be completed during one assessment session which will take up to four hours. A subset of patients will undergo the assessment twice, eight weeks apart, to monitor progress over time with usual treatment. This subset will be comprised of participants in the chronic cough group who are currently undergoing treatment for their coughing. In this subset, the treatment will not be completed as part of the study i.e., the group are being assessed prior to and after eight weeks of treatment; change over time is being assessed rather than a specific therapeutic protocol. The assessments will be conducted by a Speech-Language Therapist (SLT)/PhD student. The individual is trained and competent to conduct all assessments, and is certified to practice First Aid. Assessment will be conducted face-to-face, with a single participant per each session. The study will be completed at the University of Canterbury Rose Centre for Stroke Recovery and Research, a laboratory dedicated to investigation of swallowing and voice.

Sponsors

University of Canterbury
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Other
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

For the chronic cough group: - 18 years and over - Able to consent to study - Frequent coughing lasting longer than eight weeks (Morice et al., 2020) - Optimal management of chronic cough without resolution, prompting referring respiratory physician to consider behavioural cough control therapy For the healthy group: - 18 years and over - Able to consent to the study

Exclusion criteria

For the chronic cough group: - Patient has not received sufficient prior assessment and/or treatment of chronic cough on respiratory physician's review of health information - Structural abnormalities of the lower airways including emphysema, bronchiectasis, pulmonary fibrosis, or sarcoidosis - Chronic obstructive pulmonary disease - Smoking or vaping in the last 6 months - Upper respiratory tract infection in the last two weeks - Uncontrolled reflux - Use of opioids in the last six months - Use of ACE inhibitors in the last six months - Current use of neuromodulatory medicines - Use of spirometry is contraindicated - Previous or current behavioural treatment for chronic cough by a Speech-Language Therapist or physiotherapist - Arrived from overseas in the last 14 days - Displaying symptoms of Covid-19 in the last 14 days - Been in close physical contact with someone with a suspected or confirmed case of Covid-19 in the last 14 days - Lack of full vaccination against Covid-19, or unable to prove full vaccination using My Vaccine Pass - Allergy or intolerance to wheat or gluten For the healthy group: - History of frequent coughing lasting longer than eight weeks Structural abnormalities of the lower airways including emphysema, bronchiectasis, pulmonary fibrosis, or sarcoidosis - Chronic obstructive pulmonary disease - Smoking or vaping in the last 6 months - Upper respiratory tract infection in the last two weeks - Uncontrolled reflux - Use of opioids in the last six months - Use of ACE inhibitors in the last six months - Current use of neuromodulatory medicines - Use of spirometry is contraindicated - Arrived from overseas in the last 14 days - Displaying symptoms of Covid-19 in the last 14 days - Been in close physical contact with someone with a suspected or confirmed case of Covid-19 in the last 14 days - Lack of full vaccination against Covid-19, or unable to prove full vaccination using My Vaccine Pass - Allergy or intolerance to wheat or gluten

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026